Capital award for UK DRI at Imperial College London

Lead Research Organisation: Imperial College London

Abstract

Alongside significant co-investment from Imperial College London, the expected outcome of this funding is the concluded refurbishment of a floor in the new Michael Uren with space for 64+ researchers. An interim solution at the Burlington Danes facility at Hammersmith campus is being used before completion of the final location at the Michael Uren, ready for occupancy by September 2019.
Additionally, £1.5m for procurement of capital equipment is being provided to assist the UK DRI in implementing its first scientific programmes (funding provided separately).
Together, the building and equipment will provide the location for, in the initial stages of 5 programmes, and then to grow significantly in number in subsequent years. The UK DRI as a whole will help to cement the UK’s world-leading position by also promoting innovate approaches and forging much closer collaboration and integration of on-going UK research efforts. The new institute has been established to lead the UK’s dementia research effort and forms a core part of achieving the Prime Minister’s Challenge on Dementia 2020.

Technical Summary

The aim of this award is to support Imperial College London with capital investment for setting-up of one of six UK Dementia Research Institute (UK DRI) centres; in particular, the capital required for building, refurbishment and the procurement of equipment.

At present, 5 programmes have been selected planned for the UK DRI at Imperial College London and with scientific and operational leadership provided by its associate director, Professor Paul Matthews. The project at Imperial College London will involve refurbishment of a floor in the new Michael Uren with space for 64+ researchers. An interim solution at the Burlington Danes facility at Hammersmith campus is being used before completion of the final location at the Michael Uren, ready for eventual occupancy by September 2019.

The approach of the institute as a whole, of which the UK DRI at Imperial College London forms a core part, is to amplify and enhance, not replace, current dementia research efforts in the UK. The UK DRI will help to cement the UK’s world-leading position by supplying vital new funding for research, coupled to promoting innovate approaches and forging much closer collaboration and integration of on-going UK research efforts.

There is a gap in our knowledge of how the healthy brain functions and what leads to its degeneration. The UK DRI will fill this crucial gap that exists at the start of the dementia research journey. It will study the healthy brain and neurodegeneration in order to build new knowledge and understanding that will lead to new treatments. It will also proactively connect to existing clinical and population-level dementia initiatives – for example as being undertaken by the MRC Dementias Platform UK and through the NIHR TRC-D – to catalyse a unique national and strategic approach to confronting the dementia challenge.

In particular, the present research at the UK DRI at Imperial College London plans to look at the innovation theme, including: Individual variation in dementia within populations; Metabolic factors, microbiome and role of sleep; Glial-neuronal interactions; Novel bioelectronics technologies to modulate neurons and glia in sleep, neuroprotection and cognition Funding to these science programmes is provided separately.

Publications

10 25 50

publication icon
Dong H (2018) Mixed Neural Network Approach for Temporal Sleep Stage Classification. in IEEE transactions on neural systems and rehabilitation engineering : a publication of the IEEE Engineering in Medicine and Biology Society

 
Description Biogen REM2 snRNASeq Collaboration 
Organisation Biogen Idec
Country United States 
Sector Private 
PI Contribution Ascertainment and sequencing of nuclei from TREM2var brains
Collaborator Contribution Bioinformatics for snRNASeq analysis
Impact Pending
Start Year 2019
 
Description Edmond J Safra Foundation and Lily Safra 
Organisation Edmond J Safra Foundation
Country Liechtenstein 
Sector Charity/Non Profit 
PI Contribution Continuing dialogue with a major funder for clinical neuroscience research
Collaborator Contribution Funding of my chair and junior research fellowships, two of which have been awarded to people who will become part of UK DRI
Impact All of my outputs since 2015 should be attributed
Start Year 2014
 
Description Nodthera Inflammasome Collaboration 
Organisation NodThera
Country United Kingdom 
Sector Private 
PI Contribution Assessment of novel potential therapeutics
Collaborator Contribution Joint development of research design
Impact None yet
Start Year 2018